TY - JOUR T1 - A multicentric Spanish study on the characteristics and survival of gastric adenocarcinoma under the age of 60 JO - Gastroenterología y Hepatología (English Edition) T2 - AU - Rodríguez-de-Santiago,Enrique AU - Hernanz,Nerea AU - Marcos-Prieto,Héctor Miguel AU - de Jorge-Turrión,Miguel Ángel AU - Barreiro-Alonso,Eva AU - Rodríguez-Escaja,Carlos AU - Jiménez-Jurado,Andrea AU - Machado-Volpato,Nadja AU - Pérez-Valle,Isabel AU - García-Prada,María AU - Sierra-Morales,María AU - Ríos León,Raquel AU - Núñez Gómez,Laura AU - García García-de-Paredes,Ana AU - Castaño-García,Andrés AU - Foruny-Olcina,José Ramón AU - Peñas-García,Beatriz AU - Vázquez-Sequeiros,Enrique AU - Albillos,Agustín SN - 24443824 M3 - 10.1016/j.gastre.2019.07.001 DO - 10.1016/j.gastre.2019.07.001 UR - https://www.elsevier.es/en-revista-gastroenterologia-hepatologia-english-edition--382-articulo-a-multicentric-spanish-study-on-S2444382419302226 AB - IntroductionIn Europe, gastric adenocarcinoma (GADC) is commonly regarded as a disease of the elderly. This study aims to assess the proportion, characteristics, and survival of patients diagnosed with GADC under the age of 60. Materials and methodsThis is a retrospective, multicentric, and analytical study conducted at four tertiary Spanish hospitals. All patients diagnosed with GADC between 2008 and 2015 were included. Demographic, clinical, endoscopic, histologic, and survival data were retrieved. A multivariate analysis was performed to compare GADC in young (age≤60 years) and elderly patients. ResultsA total of 1374 patients with GADC were included. The mean age was 74 years (SD:11.1); 62.2% were males. There were 177 patients under the age of 60 (12.9%, 95% CI: 11.2–14.8%). GADC was frequently encountered as a metastatic disease in both young and elderly patients (Stage IV: 45.7% and 41%, respectively). In the multivariate analysis, alcohol abuse, ASA functional status I–II, diffuse subtype, neoadjuvant, and palliative therapy were independently associated (P<0.05) with age ≤60 years. No differences were found in 2-year survival (GADC ≤60: 39% vs. 35%, P=0.45). Curative-intent surgery, TNM stage I-II, body mass index<30kg/m2, and better functional status at diagnosis were independent predictors of survival in GADC under the age of 60. ConclusionsOne out of eight cases of GADC were diagnosed under the age of 60. Metastatic disease was frequent at diagnosis and overall survival was poor regardless of age. Factors associated with localized disease correlated with improved survival in younger patients. Our results underline the need for early diagnosis strategies in our country. ER -